RTSNRetension Pharmaceuticals, Inc.
- Market cap
- $127.06M
- as of 2026-10-23
- Latest close
- $15.25
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
2 insiders bought $369.6K between Oct 13.
Under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-10-08
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 22 | Oct 22 | A · derivative | 40,884 | $15.50 | $633,702 | 40,884 | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | P | 20,800 | $12.00 | Purchase +$249,600 | 423,377 | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | C | 9,662 | not reported | not reported | 433,039 | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | C | 31,368 | not reported | not reported | 464,407 | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | A · derivative | 255,174 | $11.63 | $2,967,674 | 255,174 | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | C · derivative | 9,662 | not reported | not reported | not reported | No | Form 4 |
| Keller Eric L.CHIEF EXECUTIVE OFFICER | Oct 13 | Oct 13 | C · derivative | 31,368 | not reported | not reported | not reported | No | Form 4 |
| Sweetnam PaulCHIEF SCIENTIFIC OFFICER | Oct 13 | Oct 13 | C | 4,026 | not reported | not reported | 406,603 | No | Form 4 |
| Sweetnam PaulCHIEF SCIENTIFIC OFFICER | Oct 13 | Oct 13 | C | 2,640 | not reported | not reported | 2,640 | No | Form 4 |
| Sweetnam PaulCHIEF SCIENTIFIC OFFICER | Oct 13 | Oct 13 | C · derivative | 4,026 | not reported | not reported | not reported | No | Form 4 |
| Sweetnam PaulCHIEF SCIENTIFIC OFFICER | Oct 13 | Oct 13 | C · derivative | 2,640 | not reported | not reported | not reported | No | Form 4 |
| Olds Donald | Oct 13 | Oct 13 | C | 5,637 | not reported | not reported | 5,637 | No | Form 4 |
| Olds Donald | Oct 13 | Oct 13 | C · derivative | 5,637 | not reported | not reported | not reported | No | Form 4 |
| Cheruvu Pavan | Oct 13 | Oct 13 | A · derivative | 5,636 | $11.63 | $65,547 | 5,636 | No | Form 4 |
| Bisson SabineCHIEF OPERATING OFFICER | Oct 13 | Oct 13 | C | 1,611 | not reported | not reported | 1,611 | No | Form 4 |
| Bisson SabineCHIEF OPERATING OFFICER | Oct 13 | Oct 13 | C | 2,504 | not reported | not reported | 4,115 | No | Form 4 |
| Bisson SabineCHIEF OPERATING OFFICER | Oct 13 | Oct 13 | C · derivative | 1,611 | not reported | not reported | not reported | No | Form 4 |
| Bisson SabineCHIEF OPERATING OFFICER | Oct 13 | Oct 13 | C · derivative | 2,504 | not reported | not reported | not reported | No | Form 4 |
| Berger Franklin M | Oct 13 | Oct 13 | C | 12,517 | not reported | not reported | 12,517 | No | Form 4 |
| Berger Franklin M | Oct 13 | Oct 13 | P | 10,000 | $12.00 | Purchase +$120,000 | 10,000 | No | Form 4 |
| Berger Franklin M | Oct 13 | Oct 13 | C · derivative | 12,517 | not reported | not reported | not reported | No | Form 4 |
| Berendt Michael J | Oct 13 | Oct 13 | C | 4,026 | not reported | not reported | 4,026 | No | Form 4 |
| Berendt Michael J | Oct 13 | Oct 13 | C | 2,640 | not reported | not reported | 6,666 | No | Form 4 |
| Berendt Michael J | Oct 13 | Oct 13 | C · derivative | 4,026 | not reported | not reported | not reported | No | Form 4 |
| Berendt Michael J | Oct 13 | Oct 13 | C · derivative | 2,640 | not reported | not reported | not reported | No | Form 4 |
| Berendt Michael J | Oct 8 | Oct 8 | A · derivative | 5,636 | $12.00 | $67,632 | 5,636 | No | Form 4 |
| Olds Donald | Oct 8 | Oct 8 | A · derivative | 5,636 | $12.00 | $67,632 | 5,636 | No | Form 4 |
| Berger Franklin M | Oct 8 | Oct 8 | A · derivative | 5,636 | $12.00 | $67,632 | 5,636 | No | Form 4 |